Regeneron Pharma (REGN) EPS Jumps and PT Rises to $690 at Piper Sandler After DOD Follow-on Contract Announcement
Tweet Send to a Friend
Piper Sandler analyst Christopher Raymond raised the price target on Regeneron Pharma (NASDAQ: REGN) to $690.00 (from $675.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
